PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists reveal parchment's hidden stories

The new technique of analyzing DNA found in ancient parchments can shine a focused light on the development of agriculture across the centuries

Scientists reveal parchment's hidden stories
2014-12-08
(Press-News.org) Dublin, IRELAND Monday December 8th, 2014 - Millions of documents stored in archives could provide scientists with the key to tracing agricultural development across the centuries, according to new research completed at Trinity College Dublin and the University of York.

Amazingly, thanks to increasingly progressive genetic sequencing techniques, the all-important historical tales these documents tell are no longer confined to their texts; now, vital information also comes from the DNA of the parchment on which they are written.

Researchers used these state-of-the-art scientific techniques to extract ancient DNA and protein from tiny samples of parchment from documents from the late 17th and late 18th centuries. The resulting information enabled them to establish the type of animals from which the parchment was made, which, when compared to genomes of their modern equivalents, provides key information as to how agricultural expansion shaped the genetic diversity of these animals.

This information therefore gives the scientists an unrivalled resource to analyse the development of livestock husbandry across the centuries. The research has just been published in the international, peer-reviewed journal Philosophical Transactions of the Royal Society B.

Professor of Population Genetics at Trinity College Dublin, Daniel Bradley, said: "This pilot project suggests that parchments are an amazing resource for genetic studies that consider agricultural development over the centuries. There must be millions stored away in libraries, archives, solicitors' offices and even in our own attics. After all, parchment was the writing material of choice for thousands of years, going back to the Dead Sea Scrolls."

He added: "Wool was essentially the oil of times gone by, so knowing how human change affected the genetics of sheep through the ages can tell us a huge amount about how agricultural practices evolved."

To conduct their research, geneticists at Trinity extracted DNA from two tiny (2x2cm) samples of parchment provided by the University of York's Borthwick Institute for Archives. Meanwhile, researchers in the Centre for Excellence in Mass Spectrometry at York extracted collagen (protein) from the same parchment samples.

The first sample showed a strong affinity with northern Britain, specifically the region in which black-faced breeds such as Swaledale, Rough Fell and Scottish Blackface are common, whereas the second sample showed a closer affinity with the Midlands and southern Britain where the livestock Improvements of the later 18th century were most active.

If other parchments show similar levels of DNA content, resulting sequencing could provide insights into the breeding history of livestock - particularly sheep - before, during and after the agricultural improvements of the 18th century that led to the emergence of regional breeds of sheep in Britain.

Professor Matthew Collins, of the Department of Archaeology at York, who heads the University's BioArCh research centre, said: "We believe the two specimens derive from an unimproved northern hill-sheep typical in Yorkshire in the 17th century, and from a sheep derived from the 'improved' flocks, such as those bred in the Midlands by Robert Bakewell, which were spreading through England in the 18th century. We want to understand the history of agriculture in these islands over the last 1,000 years and, with this breath-taking resource, we can."

INFORMATION:

The research was funded by a grant from the European Research Council. The paper can be viewed here after embargo: http://rstb.royalsocietypublishing.org/content/370/1660.toc

Media Contact:

Daniel Bradley, Professor of Population Genetics, Trinity College Dublin, at dbradley@tcd.ie, or Tel: +353-87-207-9451

Thomas Deane, Press Officer for the Faculty of Engineering, Mathematics, and Science, Trinity College Dublin, at deaneth@tcd.ie, or Tel: +353-1-896-4685

Matthew Collins, Professor of Archaeology, University of York, at matthew.collins@york.ac.uk, or Tel: +44-7955-888101

David Garner, Head of Media Relations, University of York, at david.garner@york.ac.uk or Tel: +44-1904-322153

Additional Notes to Editor

Parchment a Huge Reservoir of DNA Information

Before the mass production of paper, parchment was the major medium for legal documents and until the widespread adoption of typewriters, they were a clerk's preferred medium for many formal legal documents and records.

Parchment has a number of properties that make it compelling material for DNA extraction and analysis. Parchments are made from the skins of domestic animals, particularly livestock, and their manufacture results in robust artefacts, which can survive intact for many centuries.

Secondly, they are abundant and because of their enduring legal value they have generally been carefully managed. In the 20th century, this has included protecting them from both high temperatures and fluctuating humidity.

Thirdly, unlike bone remains, of which only a small percentage have been excavated, parchments are above ground, archived and in the case of legal documents, directly related to specific dates - a level of resolution largely unachievable with any other historic DNA source. Even undated documents can be dated palaeographically to a resolution better and more cheaply than radiocarbon dating.

About Trinity College Dublin

Trinity College Dublin, founded in 1592 is Ireland's oldest university and today has a vibrant community of 17,000 students. It is recognised internationally as Ireland's premier university. Cutting-edge research, technology and innovation places the university at the forefront of higher education in Ireland and globally.

It encompasses all major academic disciplines, and is committed to world-class teaching and research across the range of disciplines in the arts, humanities, engineering, science, social and health sciences.

Trinity is Ireland's leading university across all international rankings, and was ranked 61st globally in 2013 QS World University Rankings

http://www.tcd.ie.

** Note there is video available here: http://youtu.be/f0e-rmri89M **

** Note there are also images and captions available here: http://www.york.ac.uk/news-and-events/features/2014/parchment-hidden-story


[Attachments] See images for this press release:
Scientists reveal parchment's hidden stories Scientists reveal parchment's hidden stories 2 Scientists reveal parchment's hidden stories 3

ELSE PRESS RELEASES FROM THIS DATE:

Correcting metabolic abnormalities may help lessen urinary problems

2014-12-08
Metabolic syndrome is linked with an increased frequency and severity of lower urinary tract symptoms, but weight loss surgery may lessen these symptoms. The findings, which come from two studies published in BJU International, indicate that urinary problems may be added to the list of issues that can improve with efforts that address altered metabolism. Lower urinary tract symptoms related to urinary frequency and urgency, bladder leakage, the need to urinate at night, and incomplete bladder emptying are associated with obesity in both men and women. To see if these ...

Dartmouth/Univ. of Exeter Study: Correcting myths about the flu vaccine

2014-12-08
HANOVER, N.H. - December 8, 2014 - With health systems in the U.S., U.K., and around the world trying to increase vaccination levels, it is critical to understand how to address vaccine hesitancy and counter myths about vaccine safety. A new article in the journal "Vaccine" concludes, however, that correcting myths about vaccines may not be the most effective approach to promoting immunization among vaccine skeptics. The study, which was co-authored by Brendan Nyhan, an assistant professor of government at Dartmouth College, and Jason Reifler, a senior lecturer of politics ...

Penn researchers announce latest results of investigational cellular therapy

2014-12-08
SAN FRANCISCO - The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition. Highlights of the new trial results will include a response rate of more than 90 percent among pediatric acute lymphoblastic leukemia patients, and results from the first lymphoma trials testing the approach, including a 100 percent response rate among follicular lymphoma patients and ...

Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds

2014-12-08
Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have found in a study presented at the annual meeting of the American Society of Hematology (ASH). The study suggests that attacking those subsets with targeted drugs may degrade the disease's ability to spread throughout the bone marrow of affected patients, the authors say. The discovery was made by developing a mouse model of the disease that enabled researchers ...

Oral inhibitor shows clinical activity in poor-prognosis AML

2014-12-08
An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators from Dana-Farber Cancer Institute and M.D. Anderson Cancer Center.   Of 32 patients treated with the oral inhibitor ABT-199, five had eradication of their leukemia and several more had stable disease, according to Anthony Letai, MD, PhD, of Dana-Farber, senior author of the report.     The phase 2 multicenter trial was the first ...

Combination therapy shown as effective for higher-risk MDS/AML patients

Combination therapy shown as effective for higher-risk MDS/AML patients
2014-12-08
A phase two study that investigated the potential of the drugs azacitidine (AZA) and lenalidomide (LEN), demonstrated that the two therapies in combination may be an effective frontline treatment regimen for patients with higher-risk forms of myelodysplastic syndrome and acute myeloid leukemia. Myelodysplastic syndrome (MDS) is a type of cancer in which the bone marrow does not make enough healthy blood cells, resulting in abnormal (blast) cells in the blood and/or bone marrow. Higher-risk patients experience an unusually large percentage of blasts in their blood. Patients ...

New study identifies first gene associated with familial glioma

2014-12-07
HOUSTON - (Dec. 7, 2014) - An international consortium of researchers led by Baylor College of Medicine has identified for the first time a gene associated with familial glioma (brain tumors that appear in two or more members of the same family) providing new support that certain people may be genetically predisposed to the disease. "It is widely thought amongst the clinical community that there is no association between family history and development of glioma. Because we know very little about the contributing genetic factors, when cases occur in two or more family ...

Study shows improved survival in aggressive acute myeloid leukemia

Study shows improved survival in aggressive acute myeloid leukemia
2014-12-07
Patients who relapse in their battle with acute myeloid leukemia (AML) may benefit from a phase three study of therapies that combine an existing agent, cytarabine, with a newer compound, vosaroxin. The study, led by Farhad Ravandi, M.D, professor of medicine, department of leukemia at The University of Texas MD Anderson Cancer Center, demonstrated increased survival rates, particularly in AML patients over age 60. Ravandi's study results were presented today at the 56th Annual Meeting of the American Society of Hematology (ASH) annual conference in San Francisco and ...

Young adults with ALL benefit from therapies developed for children

2014-12-07
Results from a large, prospective clinical trial add to mounting evidence that adolescent and young adult patients--aged 16 to 39 with acute lymphoblastic leukemia (ALL)--tend to fare better when treated with high-intensity pediatric protocols than previous patients who were treated with standard adult regimens. The intergroup trial, presented at the 56th annual meeting of the American Society of Hematology, enrolled 296 adolescent and young adult patients with ALL. All participants were treated by adult hematologists-oncologists on a pediatric protocol, including four ...

Stem cell transplant without radiation or chemotherapy pre-treatment shows promise

Stem cell transplant without radiation or chemotherapy pre-treatment shows promise
2014-12-07
SAN FRANCISCO (DECEMBER 7, 2014) - Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant (HSCT) after pre-treatment with immunosuppressive drugs only. This is the first trial reporting successful transplant in dyskeratosis congenita (DC) patients without the use of any radiation or conventional cytotoxic chemotherapy beforehand. The trial's data were presented by study authors Leslie Lehmann, MD, ...

LAST 30 PRESS RELEASES:

We could soon use AI to detect brain tumors

TAMEST recognizes Lyda Hill and Lyda Hill Philanthropies with Kay Bailey Hutchison Distinguished Service Award

Establishment of an immortalized red river hog blood-derived macrophage cell line

Neural networks: You might not need to buy every ticket to win the lottery

Healthy New Town: Revitalizing neighborhoods in the wake of aging populations

High exposure to everyday chemicals linked to asthma risk in children

How can brands address growing consumer scepticism?

New paradigm of quantum information technology revealed through light-matter interaction!

MSU researchers find trees acclimate to changing temperatures

World's first visual grading system developed to combat microplastic fashion pollution

Teenage truancy rates rise in English-speaking countries

Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease

Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

New nasal vaccine shows promise in curbing whooping cough spread

Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes

Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types

For low-risk pregnancies, planned home births just as safe as birth center births, study shows

Leaner large language models could enable efficient local use on phones and laptops

‘Map of Life’ team wins $2 million prize for innovative rainforest tracking

Rise in pancreatic cancer cases among young adults may be overdiagnosis

New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors

Fewer than 1 in 5 know the 988 suicide lifeline

Semaglutide eligibility across all current indications for US adults

Can podcasts create healthier habits?

Zerlasiran—A small-interfering RNA targeting lipoprotein(a)

Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss

Oral muvalaplin for lowering of lipoprotein(a)

Revealing the hidden costs of what we eat

New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome

American soil losing more nutrients for crops due to heavier rainstorms, study shows

[Press-News.org] Scientists reveal parchment's hidden stories
The new technique of analyzing DNA found in ancient parchments can shine a focused light on the development of agriculture across the centuries